Search bioRxivSearch

bioRxiv · 10.1101/097154

A more accurate account of the effect of k-space sampling and signal decay on the effective spatial resolution in functional MRI

Abstract

The effects of k-space sampling and signal decay on the effective spatial resolution of MRI and functional MRI (fMRI) are commonly assessed by means of the magnitude point-spread function (PSF), defined as the absolute values (magnitudes) of the complex MR imaging PSF. It is commonly assumed that this magnitude PSF signifies blurring, which can be quantified by its full-width at half-maximum (FWHM). Here we show that the magnitude PSF fails to accurately represent the true effects of k-space sampling and signal decay.\n\nFirstly, a substantial part of the width of the magnitude PSF is due to MRI sampling per se. This part is independent of any signal decay and its effect depends on the spatial frequency composition of the imaged object. Therefore, it cannot always be expected to introduce blurring. Secondly, MRI reconstruction is typically followed by taking the absolute values (magnitude image) of the reconstructed complex image. This introduces a non-linear stage into the process of image formation. The complex imaging PSF does not fully describe this process, since it does not reflect the stage of taking the magnitude image. Its corresponding magnitude PSF fails to correctly describe this process, since convolving the original pattern with the magnitude PSF is different from the true process of taking the absolute following a convolution with the complex imaging PSF. Lastly, signal decay can have not only a blurring, but also a high-pass filtering effect. This cannot be reflected by the strictly positive width of the magnitude PSF.\n\nAs an alternative, we propose to first approximate the MRI process linearly. We then model the linear approximation by decomposing it into a signal decay-independent MR sampling part and an approximation of the signal decay effect. We approximate the latter as a convolution with a Gaussian PSF or, if the effect is that of high-pass filtering, as reversing the effect of a convolution with a Gaussian PSF. We show that for typical high-resolution fMRI at 7 Tesla, signal decay in Spin-Echo has a moderate blurring effect (FWHM = 0.89 voxels, corresponds to 0.44 mm for 0.5 mm wide voxels). In contrast, Gradient-Echo acts as a moderate high-pass filter that can be interpreted as reversing a Gaussian blurring with FWHM = 0.59 voxels (0.30 mm for 0.5 mm wide voxels). Our improved approximations and findings hold not only for Gradient-Echo and Spin-Echo fMRI but also for GRASE and VASO fMRI. Our findings support the correct planning, interpretation, and modeling of high-resolution fMRI.

Explore related subjects

Keep this discovery

BibTeXRIS

Chaimow, D., Shmuel, A.. 2016-12-29. A more accurate account of the effect of k-space sampling and signal decay on the effective spatial resolution in functional MRI. https://doi.org/10.1101/097154

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience